CureVac 過去の業績
この会社の最新の決算報告書はまだ処理中です
過去 基準チェック /06
CureVacの収益は年間平均-12.8%の割合で減少していますが、 Biotechs業界の収益は年間 増加しています。収益は年間19.3% 16.5%割合で 減少しています。
主要情報
-12.8%
収益成長率
98.9%
EPS成長率
| Biotechs 業界の成長 | 17.0% |
| 収益成長率 | -16.5% |
| 株主資本利益率 | -73.9% |
| ネット・マージン | -422.8% |
| 前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
CureVac: Back To Square One
Oct 08CureVac N.V.'s (NASDAQ:CVAC) Share Price Could Signal Some Risk
Sep 16
CureVac N.V.'s (NASDAQ:CVAC) Intrinsic Value Is Potentially 93% Above Its Share Price
Aug 03We're Hopeful That CureVac (NASDAQ:CVAC) Will Use Its Cash Wisely
Jul 05CureVac: GSK's Deal For Infectious Disease Assets Is A Long-Shot For Both Pharmas
Jul 04Optimistic Investors Push CureVac N.V. (NASDAQ:CVAC) Shares Up 47% But Growth Is Lacking
Jun 01We Think CureVac (NASDAQ:CVAC) Needs To Drive Business Growth Carefully
Mar 20CureVac: No Momentum In Sight
Mar 08What Does The Future Hold For CureVac N.V. (NASDAQ:CVAC)? These Analysts Have Been Cutting Their Estimates
Aug 26CureVac N.V.'s (NASDAQ:CVAC) Intrinsic Value Is Potentially 89% Above Its Share Price
Jun 14Some Analysts Just Cut Their CureVac N.V. (NASDAQ:CVAC) Estimates
May 01Analysts Have Lowered Expectations For CureVac N.V. (NASDAQ:CVAC) After Its Latest Results
Apr 29An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 46% Undervalued
Jan 08CureVac BV reports Q2 results
Aug 18CureVac claims patent rights for Pfizer/BioNTech COVID-19 vaccine
Jul 05Will CureVac (NASDAQ:CVAC) Spend Its Cash Wisely?
May 29Analysts Are Betting On CureVac N.V. (NASDAQ:CVAC) With A Big Upgrade This Week
May 02A Look At The Intrinsic Value Of CureVac N.V. (NASDAQ:CVAC)
Oct 28CureVac: Wait For Concrete News Before Investing
Sep 01CureVac plunges as COVID-19 vaccine candidate indicates below par efficacy
Jun 16An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 31% Undervalued
Jun 13CureVac tumbles on potential delay for European decision on its COVID-19 shot
Jun 08CureVac: The Moment Of Truth Arrives
Jun 01CureVac BV reports Q1 results
May 26CureVac Could Soon Join The Fight Against COVID-19
May 10収支内訳
収支内訳
CureVac の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 66 | -278 | 85 | 116 |
| 31 Mar 24 | 59 | -273 | 92 | 119 |
| 31 Dec 23 | 54 | -260 | 96 | 116 |
| 30 Sep 23 | 43 | -302 | 95 | 110 |
| 30 Jun 23 | 38 | -301 | 103 | 95 |
| 31 Mar 23 | 50 | -291 | 106 | 76 |
| 31 Dec 22 | 67 | -249 | 107 | 63 |
| 30 Sep 22 | 97 | -122 | 100 | 566 |
| 30 Jun 22 | 115 | -219 | 103 | 602 |
| 31 Mar 22 | 117 | -313 | 105 | 722 |
| 31 Dec 21 | 103 | -412 | 102 | 816 |
| 30 Sep 21 | 68 | -468 | 102 | 322 |
| 30 Jun 21 | 44 | -361 | 81 | 308 |
| 31 Mar 21 | 56 | -219 | 64 | 208 |
| 31 Dec 20 | 49 | -129 | 54 | 114 |
| 30 Sep 20 | 50 | -107 | 56 | 89 |
| 31 Mar 20 | 17 | -102 | 56 | 43 |
| 31 Dec 19 | 17 | -100 | 51 | 43 |
| 31 Dec 18 | 13 | -71 | 26 | 42 |
質の高い収益: CVACは現在利益が出ていません。
利益率の向上: CVACは現在利益が出ていません。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: CVACは利益が出ておらず、過去 5 年間で損失は年間12.8%の割合で増加しています。
成長の加速: CVACの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: CVACは利益が出ていないため、過去 1 年間の収益成長をBiotechs業界 ( 16.6% ) と比較することは困難です。
株主資本利益率
高いROE: CVACは現在利益が出ていないため、自己資本利益率 ( -73.95% ) はマイナスです。